Tuberculous peritonitis after treatment with adalimumab

Author： Antolin Jose   Azahara Marcos   Hernandez Clara   Blanco Margarita   Mao Laura   Ciguenza Ramon  

Publisher： Informa Healthcare

ISSN： 0036-5548

Source： Scandinavian Journal of Infectious Diseases, Vol.40, Iss.8, 2008-01, pp. : 677-678

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adalimumab treatment may replace or enhance the activity of steroids in steroid-refractory tuberculous meningitis

By Lee Ho-Su  

Journal of Infection and Chemotherapy, Vol. 18, Iss. 4, 2012-08 ,pp. : 555-557

Springer Publishing Company

Access to resources Recommend Favorite

Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 10, 2013-11 ,pp. : 1236-1247

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tuberculous peritonitis with infracarinal mass and elevated CA-125 in a 13-year-old girl

By Menke Jan   Kühnle Ingrid  

Infection, Vol. 42, Iss. 2, 2014-04 ,pp. : 415-418

Springer Publishing Company

Access to resources Recommend Favorite

Successful treatment of generalized granuloma annulare with adalimumab

By  

CLINICAL & EXPERIMENTAL DERMATOLOGY, Vol. 40, Iss. 5, 2015-07 ,pp. : 537-539

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adalimumab in the treatment of refractory adult‐onset Still's disease

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 20, Iss. 11, 2017-11 ,pp. : 1798-1799

John Wiley & Sons Inc

Access to resources Recommend Favorite